Amgen Inc. buy phonebroker
Start price
03.11.16
/
50%
€123.55
Target price
03.03.17
€162.36
Performance (%)
33.25%
End price
03.03.17
€162.70
Summary
This prediction ended on 03.03.17 with a price of €162.70. With a performance of 33.25% the BUY prediction by phonebroker was a big success. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 1.589% | 1.589% | 17.696% | 41.571% |
| iShares Core DAX® | 2.901% | 3.653% | 5.756% | 49.364% |
| iShares Nasdaq 100 | 4.597% | 3.057% | 36.946% | 89.089% |
| iShares Nikkei 225® | 10.422% | 12.613% | 64.975% | 72.729% |
| iShares S&P 500 | 2.574% | 1.362% | 25.173% | 65.392% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 03.11.2016 dem Buy-Gesamtsentiment mit dem Kursziel 180 USD zu.